Verseon Corporation Additional Listing & Total Voting Rights (6720R)
04 3월 2019 - 4:01PM
UK Regulatory
TIDMVSN
RNS Number : 6720R
Verseon Corporation
04 March 2019
March 4, 2019
Verseon Corporation
("Verseon" or the "Company")
Additional Listing & Total Voting Rights
Fremont, Calif.-Verseon, a technology-based pharmaceutical
company, announces that application has been made for 4,375 new
shares of common stock ("Common Shares") of par value $0.001 each
to be admitted to trading on AIM pursuant to regularly scheduled
vesting of restricted stock units (the "Issuance").
The 4,375 new Common Shares issued pursuant to the Issuance will
rank pari passu with the Company's existing Common Shares and
admission to trading on AIM is expected to take place on March 7,
2019 ("Admission").
Total Voting Rights
Following Admission, the issued share capital of the Company
will consist of 151,699,413 Common Shares and the Company will hold
42,917 shares in treasury. Therefore, the total number of Common
Shares in the Company with voting rights will be 151,656,496. This
figure may be used by shareholders in the Company as the
denominator for the calculations by which they will determine if
they are required to notify their interest in, or a change in their
interest in, the share capital of the Company under the FCA's
Disclosure and Transparency Rules.
Other Information
Further to the announcement of November 6, 2018, Verseon also
confirms the completion of normal and customary regulatory
diligence on Sangtae Kim, a non-executive director of the Company.
In relation to Mr. Kim's appointment, the following information is
disclosed pursuant to Schedule 2, paragraph (g) of the AIM Rules
for Companies:
Full Name: Sangtae Kim
Age: 60
--------------------------------------
Current Directorships Purdue University
/
Partnership:
--------------------------------------
Previous Directorships Prowd Sciences Inc.
/ The Morgridge Institute for Research
Partnership in the Inc.
past 5 years:
--------------------------------------
Shareholding in the Nil
Company:
--------------------------------------
- Ends -
For further information, please contact:
Verseon Corporation www.verseon.com
Sebastian Wykeham / Tina Schlafly +1 (510) 225 9000
Arden Partners (NOMAD and Joint Broker)
Ruari McGirr / Ciaran Walsh / Alex +44 (0) 20 7614
Penney 5900
Cantor Fitzgerald Europe (Joint Broker)
+44 (0) 20 7894
Phil Davies 7000
For financial and business media enquiries, please contact
Buchanan Communications Ltd (PR Advisers)
+44 (0) 20 7466
Henry Harrison-Topham / Jamie Hooper 5000
For trade and pharma media enquiries, please contact
Vane Percy & Roberts
+44 (0) 1737 821
Simon Vane Percy 890
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
ALSJJMFTMBMMBBL
(END) Dow Jones Newswires
March 04, 2019 02:01 ET (07:01 GMT)
Verseon (LSE:VSN)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
Verseon (LSE:VSN)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024